SK103093A3 - New active compounds - Google Patents

New active compounds Download PDF

Info

Publication number
SK103093A3
SK103093A3 SK1030-93A SK103093A SK103093A3 SK 103093 A3 SK103093 A3 SK 103093A3 SK 103093 A SK103093 A SK 103093A SK 103093 A3 SK103093 A3 SK 103093A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
pyridine
group
mmol
Prior art date
Application number
SK1030-93A
Other languages
English (en)
Slovak (sk)
Inventor
Carian Briving
Marie Elebring
Stig Carlsson
Robert Carter
Thomas Kuhler
Peter Nordberg
Ingemar Starke
Arne Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK103093A3 publication Critical patent/SK103093A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1030-93A 1991-03-27 1992-03-25 New active compounds SK103093A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100920A SE9100920D0 (sv) 1991-03-27 1991-03-27 New active compounds
PCT/SE1992/000190 WO1992017477A1 (en) 1991-03-27 1992-03-25 New active compounds

Publications (1)

Publication Number Publication Date
SK103093A3 true SK103093A3 (en) 1994-08-10

Family

ID=20382295

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1030-93A SK103093A3 (en) 1991-03-27 1992-03-25 New active compounds

Country Status (30)

Country Link
US (1) US5439917A (enExample)
EP (2) EP0509974B1 (enExample)
JP (1) JP3122792B2 (enExample)
CN (1) CN1067892A (enExample)
AP (1) AP309A (enExample)
AT (1) ATE175672T1 (enExample)
AU (1) AU655634B2 (enExample)
BG (1) BG98124A (enExample)
CA (1) CA2106880A1 (enExample)
DE (1) DE69228142T2 (enExample)
DK (1) DK0509974T3 (enExample)
ES (1) ES2129039T3 (enExample)
FI (1) FI934203A0 (enExample)
GR (1) GR3029834T3 (enExample)
HU (1) HUT65948A (enExample)
IE (1) IE920915A1 (enExample)
IL (1) IL101347A0 (enExample)
IS (1) IS3827A (enExample)
JO (1) JO1704B1 (enExample)
MA (1) MA22477A1 (enExample)
MX (1) MX9201324A (enExample)
NO (1) NO933425L (enExample)
NZ (1) NZ241943A (enExample)
SE (1) SE9100920D0 (enExample)
SK (1) SK103093A3 (enExample)
TN (1) TNSN92026A1 (enExample)
TW (1) TW198032B (enExample)
WO (1) WO1992017477A1 (enExample)
YU (1) YU30292A (enExample)
ZA (1) ZA921823B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
DZ3377A1 (fr) * 1999-12-24 2001-07-05 Aventis Pharma Ltd Azaindoles
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1490364B1 (en) * 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
GB0305142D0 (en) * 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
PL1606261T3 (pl) 2003-03-10 2010-04-30 Astrazeneca Ab Nowy sposób przygotowania roflumilastu
US6981980B2 (en) 2003-03-19 2006-01-03 Phagia Technology Self-inflating intragastric volume-occupying device
US7612086B2 (en) * 2003-05-16 2009-11-03 Eisai R & D Management Co. Ltd. JNK inhibitors
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
GB0516156D0 (en) * 2005-08-05 2005-09-14 Eisai London Res Lab Ltd JNK inhibitors
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100920D0 (sv) * 1991-03-27 1991-03-27 Astra Ab New active compounds

Also Published As

Publication number Publication date
MA22477A1 (fr) 1992-10-01
IE920915A1 (en) 1992-10-07
NZ241943A (en) 1993-12-23
NO933425L (no) 1993-10-25
WO1992017477A1 (en) 1992-10-15
ES2129039T3 (es) 1999-06-01
CA2106880A1 (en) 1992-09-28
ZA921823B (en) 1992-11-25
TW198032B (enExample) 1993-01-11
AU1426092A (en) 1992-11-02
FI934203A7 (fi) 1993-09-24
ATE175672T1 (de) 1999-01-15
AP309A (en) 1994-01-13
EP0509974B1 (en) 1999-01-13
HU9302741D0 (en) 1993-12-28
DE69228142D1 (de) 1999-02-25
HUT65948A (en) 1994-08-29
DE69228142T2 (de) 1999-07-22
AU655634B2 (en) 1995-01-05
FI934203L (fi) 1993-09-24
SE9100920D0 (sv) 1991-03-27
IS3827A (is) 1992-09-28
JPH06506448A (ja) 1994-07-21
YU30292A (sh) 1995-01-31
DK0509974T3 (da) 1999-08-30
IL101347A0 (en) 1992-11-15
US5439917A (en) 1995-08-08
TNSN92026A1 (fr) 1993-06-08
BG98124A (bg) 1994-11-15
CN1067892A (zh) 1993-01-13
EP0509974A1 (en) 1992-10-21
JP3122792B2 (ja) 2001-01-09
FI934203A0 (fi) 1993-09-24
EP0580616A1 (en) 1994-02-02
AP9200369A0 (en) 1992-04-30
MX9201324A (es) 1992-10-01
NO933425D0 (no) 1993-09-24
GR3029834T3 (en) 1999-06-30
JO1704B1 (en) 1992-12-15

Similar Documents

Publication Publication Date Title
SK103093A3 (en) New active compounds
RU2238271C2 (ru) Производные имидазопиридина, способы их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которых вовлечено инфицирование h.pylori
RU2193036C2 (ru) Производные имидазо[1,2-а]пиридина, способы их получения, фармацевтический препарат на их основе, способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которые вовлечено инфицирование h.pylori
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
RU2167874C2 (ru) Производные хинолин-2(1н)-она, способы их получения, лекарственное средство и фармацевтическая композиция на их основе
DE3614132A1 (de) 1,3-dihydro-2h-imidazo(4,5-b)chinolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel
KR100339059B1 (ko) 이미다조[1,2-a]피리딘의알콕시알킬카르바메이트
JP2517725B2 (ja) 1H,3H−ピロロ〔1,2−c〕チアゾ−ル誘導体、その製造法および薬としての用途
IE840655L (en) 1,3-thiazolidine derivatives
NO311672B1 (no) Nye forbindelser, farmasöytisk preparat inneholdende slike forbindelser, deres anvendelser, og fremgangsmåter for deresfremstilling
JPS623153B2 (enExample)
HU191895B (en) Process for producing 2-guanidino-4-imidazolyl-thiazoles
JP2008514729A (ja) スピロ−ヒダントイン化合物の結晶形および製造方法
KR102465988B1 (ko) 항암, 항염증 효능을 가진 삼원환의 약학적 조성물
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
JP3269658B2 (ja) フェノール誘導体
FR2523972A1 (fr) Derives vinyliques substitues de la 1h-pyrazolo-(1,5-a) pyrimidine utiles notamment comme medicaments antiulcerigenes et antisecretoires gastriques et procede de leur preparation
JPH07101941A (ja) 2−[2−(置換アミノ)ベンジルチオ]−5,6, 7,8−テトラヒドロ−4(3h)−キナゾリノン誘 導体
JP3504972B2 (ja) 2−[2−(置換アミノ)ベンジルチオ]−5,6,7,8−テトラヒドロピリド[3,4−d]ピリミジン−4(3H)−オン誘導体
IE48355B1 (en) Imidazo(1,2-a)imidazole derivatives
JPH0525170A (ja) ピリドン誘導体、その製造法及びそれを含有する抗潰瘍剤
JPH10505331A (ja) ベンジルイミダゾピリジン
JPH0220609B2 (enExample)
JPS5883681A (ja) 4−シクロアルキルアミノキナゾリン誘導体
JPS6038397B2 (ja) チアジノイミダゾ−ル誘導体及びその製造法